-
Mashup Score: 0Safety and efficacy of obe-cel in R/R adult B-ALL: results of the pivotal FELIX study - 12 month(s) ago
Claire Roddie, MD, PhD, University College London Cancer Institute, London, UK, comments on the results from the Phase Ib/II FELIX…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4VJHemOnc – The video journal of hematological oncology - 12 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#EHA2023 ❘ We had a great interview with @ValentinOrtizMD (@hospitalclinic) about CART19 treatment in NHL and ALL. Stay tuned for the full interview, which will be posted on https://t.co/O9p0vDBrzw 🎥 @EHA_Hematology #NonHodgkinLymphoma #ALLsm #CART https://t.co/K7rzJugPMF https://t.co/gGqti37aEo
-
#EHA2023 ❘ A lovely discussion between Lydia Scarfò (@MyUniSR) and @Othman_Al_Sawaf (@UniCologne) on next-generation BTK inhibitors in #CLL. Stay tuned for the full discussion on https://t.co/O9p0vDBZp4 🎥 @EHA_Hematology #CLLsm #Leukemia #HemOnc https://t.co/S0O2lsLgUo
-
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 12 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#EHA2023 ❘ We just spoke with @ValentinOrtizMD (@hospitalclinic) about CART19 treatment in NHL and AML. Stay tuned for the full interview, which will be posted on https://t.co/O9p0vDBrzw @EHA_Hematology #NonHodgkinLymphoma #ALLsm #CART #CaxTx https://t.co/vR2ujugpPt
-
-
Mashup Score: 0iwCAR-T 2023 | VJHemOnc - 12 month(s) ago
Session I Toxicity prophylaxis and treatment Right? I mean, I think, I think it was interesting, we, we talked a lot about really the idea that ICANS neurotoxicity is a cytokine-driven process. And obviously the first logical thing to block was IL-6. And the early prophylactic interventions using Tocilizumab, the IL-6 receptor blocker really didn’t lead to decreased risk rates of ICANS, but…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Discover all the latest CAR-T updates in CLL, lymphoma, myeloma, ALL, and AML w/ our exclusive roundtable discussions from #iwCART23. Find them all below: 👉 https://t.co/cai1q76da5 👈 #CARTcell #ImmunoOnc #LeuSM #LymSM #CLLsm #AMLsm #ALLsm https://t.co/mOhKXJg9yh
-
-
Mashup Score: 0
Obecabtagene autoleucel produced a high response rate in adults with relapsed/refractory B-ALL in a phase 2 study.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The CAR T-cell therapy obecabtagene autoleucel produced an ORR of 76% in adults with rel/ref B-ALL in the phase 2 FELIX study. #ASCO23 #allsm #leusm https://t.co/svi8N4J2qe
-
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 12 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Starting the 2nd day of #ASCO23 with talking to @drclaireroddie from @uclcancer about the FELIX study, and updates at the UCL #CARTcell program! Watch her interviews and many more at @ASCO on https://t.co/O9p0vDBrzw💻 #immunotherapy #ALLsm #leusm #ImmunoOnc https://t.co/LZ5ditvcVX
-
-
Mashup Score: 1
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our latest podcast, where leading experts Bijal Shah, Claire Roddie, Nirav Shah & Rebecca Gardner discuss challenges with CAR-T therapy in ALL, strategies to improve clinical outcomes & more: 🎧 https://t.co/zVIvY75TDi #LeuSM #ALLsm #CARTcell #ImmunoOnc https://t.co/NeSS1bUvNC
-
-
Mashup Score: 0iwCAR-T 2023 | VJHemOnc - 1 year(s) ago
Session I Toxicity prophylaxis and treatment Right? I mean, I think, I think it was interesting, we, we talked a lot about really the idea that ICANS neurotoxicity is a cytokine-driven process. And obviously the first logical thing to block was IL-6. And the early prophylactic interventions using Tocilizumab, the IL-6 receptor blocker really didn’t lead to decreased risk rates of ICANS, but…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#iwCART2023 was filled with several informative sessions with leading experts who discussed the latest CAR-T updates in all areas of #hemonc. Check them out here: 👉https://t.co/wkgMtM20Kg👈 #HemOnc #CARTcell #ImmunoOnc #LeuSM #LymSM #ALLsm #CLLsm #MMsm https://t.co/WF0QeTxqKQ
-
-
Mashup Score: 3
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tune in to this week's podcast, where you'll hear from Bijal Shah (@MoffittNews), @drclaireroddie, Rebecca Gardner (@seattlechildren) & Nirav Shah (@MedicalCollege), who discuss challenges with bringing CAR-T to ALL & future outlooks: 🎧 https://t.co/k0HJatDewp #LeuSM #ALLsm https://t.co/PmZi73IPK5
-
-
Mashup Score: 0iwCAR-T 2023 | VJHemOnc - 1 year(s) ago
Session I Toxicity prophylaxis and treatment Right? I mean, I think, I think it was interesting, we, we talked a lot about really the idea that ICANS neurotoxicity is a cytokine-driven process. And obviously the first logical thing to block was IL-6. And the early prophylactic interventions using Tocilizumab, the IL-6 receptor blocker really didn’t lead to decreased risk rates of ICANS, but…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed out on #iwCART2023? Don't worry! All our expert-led sessions can be found on our site - hear the latest updates in CAR-T therapy in lymphoma, ALL, CLL & more from leading experts: 👉https://t.co/SVMu3P57KI👈 #CARTcell #ImmunoOnc #CLLsm #LeuSM #LymSM #ALLsm #AMLsm https://t.co/YjR3KdQooX
-
#ASCO23 | We caught up with @drclaireroddie of @uclcancer, who shared some results from the FELIX trial, which is evaluating the safety & efficacy of obe-cel in R/R adult B-ALL. Watch: 👉 https://t.co/q0WNLyAn0a 👈 @ASCO #HemOnc #Leusm #ALLsm #ImmunoOnc #CARTcell #CIM23